Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems - ScienceDirect
![Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1773224721001155-fx1.jpg)
![](https://www.thelancet.com/cms/asset/9fc10f3c-b237-4c32-95b4-8208e5f9b1a1/gr1a.jpg)
Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases
![](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12951-023-01971-7/MediaObjects/12951_2023_1971_Fig4_HTML.png)
Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects, Journal of Nanobiotechnology
![](https://www.thelancet.com/cms/attachment/d6219c58-2385-4eea-93ff-0243ce87d824/gr1.gif)
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Respiratory Medicine
![](https://ars.els-cdn.com/content/image/1-s2.0-S2405844022001049-gr3.jpg)
Theoretical effectiveness of steam inhalation against SARS-CoV-2 infection: updates on clinical trials, mechanism of actions, and traditional approaches - ScienceDirect
![](https://www.thelancet.com/cms/attachment/f54d015e-c0f4-4c10-aa00-60d99cbb93c1/gr1_lrg.jpg)
Inhaled corticosteroids: not just for asthma, but for COVID-19? - The Lancet Respiratory Medicine
![](https://ars.els-cdn.com/content/image/1-s2.0-S2211383522004002-ga1.jpg)
Localized delivery of nanomedicine and antibodies for combating COVID-19 - ScienceDirect
![](https://ars.els-cdn.com/content/image/1-s2.0-S075333222100946X-ga1.jpg)
Nanoparticles as an effective drug delivery system in COVID-19 - ScienceDirect
![](https://ars.els-cdn.com/content/image/1-s2.0-S1748013220301894-fx1.jpg)
Insights from nanotechnology in COVID-19 treatment - ScienceDirect
![](https://www.thelancet.com/cms/attachment/ea33aa2b-93d5-4d92-8c1b-c5c8b712869c/gr3.jpg)
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation - The Lancet Respiratory Medicine
![](https://ars.els-cdn.com/content/image/1-s2.0-S156713482200051X-gr3.jpg)
Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage - ScienceDirect
![](https://ars.els-cdn.com/content/image/1-s2.0-S1748013220301304-gr1.jpg)
Nanomedicine strategies to target coronavirus - ScienceDirect
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-021-00733-x/MediaObjects/41392_2021_733_Fig1_HTML.png)
Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12985-022-01935-7/MediaObjects/12985_2022_1935_Fig3_HTML.png)
Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview, Virology Journal
![](https://ars.els-cdn.com/content/image/1-s2.0-S1567576921009644-ga1.jpg)
COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends - ScienceDirect
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41581-022-00642-4/MediaObjects/41581_2022_642_Fig1_HTML.png)
Therapeutic advances in COVID-19